Switching off the enzyme that adds protective caps to chromosome ends could help fight many types of cancer, A*STAR researchers have shown. The team demonstrated the treatment's potential by using it to thwart tumor growth ...
Dec 20, 2018
0
8
Small RNA molecules in saliva could be used to detect the virus that causes hand, foot and mouth disease, enabling early intervention to limit spread of the infection.
Dec 20, 2018
0
1
Not all chronic hepatitis B (HBV) patients require lifelong treatment; but the risks of blindly withdrawing treatment can be severe. However, there's little consensus on which patients can be safely discontinued from treatment, ...
Nov 30, 2018
0
9
A protein crucial for cell division may help to explain why certain cancer therapies are more effective in some patients than others. Genetically altered regulation of this protein has helped A*STAR researchers better understand ...
Nov 30, 2018
0
1
Genome editing technology is helping A*STAR scientists unravel how the Influenza A virus (IAV) exploits human anti-viral responses.
Nov 30, 2018
0
2
Blood cells grown in large vats from a starter stock of stem cells could one day supplement or even replace blood taken from human donors. However, existing protocols for making red blood cells (RBCs) in the lab can't be ...
Nov 30, 2018
0
3
A team of scientists from Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS) has identified a new approach to cancer therapeutics by targeting the evolution of cancer cells. This approach ...
Nov 28, 2018
0
2
An international team of scientists have confirmed that both rare and common mutations of our genes are linked to the development of breast cancer, including tumour characteristics and corresponding deadliness. Interestingly, ...
Nov 2, 2018
0
0
An environmentally responsible formulation process that makes the immunosuppressant drug, Tacrolimus (TAC) more soluble, and hence more readily absorbed by the body, has been developed by A*STAR scientists.
Oct 4, 2018
0
3
A particular type of white blood cell becomes more pro-inflammatory as it deteriorates with age or 'senesce', according to research led by A*STAR scientists.
Oct 4, 2018
0
0
